
    
      Patients with atrial fibrillation receiving Dabigatran or warfarin anticoagulation therapy
      was screened and signed to two group: Dabigatran group and Warfarin group. D-dimer test was
      analyzed before and 3 months after anticoagulation starting specificly. Patients were
      followed-up for at least 12 months,and clinical outcomes, including thrombotic events major
      bleeding events and all-cause deaths were recorded during follow-up period.
    
  